The Latest in Gene Therapy Research
Gene therapy was the topic at the Healthcare Businesswomen’s Association event on…
Highlights from the World Orphan Drug Congress 2013
A key theme of the World Orphan Drug Congress 2013 was the…
The Importance of Patient Advocates for Orphan Drugs
I attended the World Orphan Drug Congress last week in Washington, DC,…
A Chat With Rare Disease Advocate Ed Fennell
Last week I had a fascinating phone conversation with rare disease advocate,…
FDA’s Dr. Katz Talks Social Media and Clinical Trials
I was fortunate to be invited to speak at the American Society…
FindZebra: Rare Disease Search Engine
Physicians are trained to arrive at a medical diagnosis by starting with…
Does FTC Social Media Guidance Provide Clues for Pharma?
The pharmaceutical industry has yet to receive specific guidance from the U.S.…
FDA Warning Letter: Don’t Make Unsubstantiated Claims, Even on Facebook
In December 2012, the FDA sent a warning letter to Amarc Enterprises…
FDA Letter Mentions Internal Site Search
We recently reviewed this FDA warning letter sent on January 29, 2013…
The Importance of Content Marketing For Orphan Drugs
Content marketing is currently a hot trend, but in the rare disease…